FibroBiologics, Inc.
FBLGNasdaqCIK 1958777HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | period not labelled2023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $k | 571Research and development, period not labelled, three months to 2023-09-30$571.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | 773Research and development, Q4 FY2023, three months to 2023-12-31$773.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001641172-25-001691. Derived: 12-month figure less the 9-month figure.Report this figure | 960Research and development, Q1 FY2024, three months to 2024-03-31$960.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | 975Research and development, Q2 FY2024, three months to 2024-06-30$975.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-31, accession 0000950170-25-100917.Report this figure | 1,213Research and development, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 1,356Research and development, Q4 FY2024, three months to 2024-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | 1,780Research and development, Q1 FY2025, three months to 2025-03-31$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 2,041Research and development, Q2 FY2025, three months to 2025-06-30$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 2,789Research and development, Q3 FY2025, three months to 2025-09-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 797Research and development, Q4 FY2025, three months to 2025-12-31$797.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | 2,953Research and development, Q1 FY2026, three months to 2026-03-31$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 1,658Research and development, Q2 FY2026, three months to 2026-06-30$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
| Operating income | $k | (2,052)Operating income, period not labelled, three months to 2023-09-30−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | (2,480)Operating income, Q4 FY2023, three months to 2023-12-31−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001641172-25-001691. Derived: 12-month figure less the 9-month figure.Report this figure | (3,450)Operating income, Q1 FY2024, three months to 2024-03-31−$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | (3,224)Operating income, Q2 FY2024, three months to 2024-06-30−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-31, accession 0000950170-25-100917.Report this figure | (3,352)Operating income, Q3 FY2024, three months to 2024-09-30−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | (3,712)Operating income, Q4 FY2024, three months to 2024-12-31−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | (4,531)Operating income, Q1 FY2025, three months to 2025-03-31−$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | (4,490)Operating income, Q2 FY2025, three months to 2025-06-30−$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | (5,038)Operating income, Q3 FY2025, three months to 2025-09-30−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | (2,590)Operating income, Q4 FY2025, three months to 2025-12-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | (5,068)Operating income, Q1 FY2026, three months to 2026-03-31−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | (4,033)Operating income, Q2 FY2026, three months to 2026-06-30−$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
| Interest expense | $k | not reported | not reported | 4.0Interest expense, Q1 FY2024, three months to 2024-03-31$4.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-14, accession 0001493152-24-019225.Report this figure | 5.0Interest expense, Q2 FY2024, three months to 2024-06-30$5.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-07, accession 0001493152-24-030603.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | not reported | not reported | not reported | not reported | 0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-31, accession 0001193125-25-260774. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-31, accession 0001193125-26-328454. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-31, accession 0001193125-25-260774. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-31, accession 0001193125-26-328454. Derived: 6-month figure less the 3-month figure.Report this figure |
| Net income | $k | (2,193)Net income, period not labelled, three months to 2023-09-30−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | (9,717)Net income, Q4 FY2023, three months to 2023-12-31−$9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001641172-25-001691. Derived: 12-month figure less the 9-month figure.Report this figure | (8,460)Net income, Q1 FY2024, three months to 2024-03-31−$8.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 898Net income, Q2 FY2024, three months to 2024-06-30$898.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | (500)Net income, Q3 FY2024, three months to 2024-09-30−$500.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | (3,099)Net income, Q4 FY2024, three months to 2024-12-31−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | (4,966)Net income, Q1 FY2025, three months to 2025-03-31−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | (4,658)Net income, Q2 FY2025, three months to 2025-06-30−$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | (5,778)Net income, Q3 FY2025, three months to 2025-09-30−$5.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | (3,244)Net income, Q4 FY2025, three months to 2025-12-31−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | (5,000)Net income, Q1 FY2026, three months to 2026-03-31−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | (4,117)Net income, Q2 FY2026, three months to 2026-06-30−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
| Diluted EPS | $ per share | (0.08)Diluted EPS, period not labelled, three months to 2023-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | not reported | (0.27)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | 0.03Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-31, accession 0000950170-25-100917.Report this figure | (0.01)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | not reported | (2.71)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | (2.41)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$2.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | (0.13)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | not reported | (1.33)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | (0.66)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
| Basic EPS | $ per share | (0.08)Basic EPS, period not labelled, three months to 2023-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | not reported | (0.27)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | 0.03Basic EPS, Q2 FY2024, three months to 2024-06-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-31, accession 0000950170-25-100917.Report this figure | (0.01)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | not reported | (2.71)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | (2.41)Basic EPS, Q2 FY2025, three months to 2025-06-30−$2.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | (0.13)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | not reported | (1.33)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | (0.66)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
Balance sheet
| Line item | Unit | period not labelled2023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | not reported | 9.2Cash and equivalents, FY2023, at 2023-12-31$9.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001641172-25-001691.Report this figure | 8.2Cash and equivalents, Q1 FY2024, at 2024-03-31$8.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001493152-24-019225.Report this figure | 6.0Cash and equivalents, Q2 FY2024, at 2024-06-30$6.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0001493152-24-030603.Report this figure | 7.8Cash and equivalents, Q3 FY2024, at 2024-09-30$7.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | 14.0Cash and equivalents, FY2024, at 2024-12-31$14.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001193125-26-066965.Report this figure | 8.7Cash and equivalents, Q1 FY2025, at 2025-03-31$8.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | 8.8Cash and equivalents, Q2 FY2025, at 2025-06-30$8.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-31, accession 0000950170-25-100917.Report this figure | 4.9Cash and equivalents, Q3 FY2025, at 2025-09-30$4.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 4.9Cash and equivalents, FY2025, at 2025-12-31$4.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 1.5Cash and equivalents, Q1 FY2026, at 2026-03-31$1.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 3.5Cash and equivalents, Q2 FY2026, at 2026-06-30$3.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
| Current assets | $m | not reported | 9.2Current assets, FY2023, at 2023-12-31$9.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001641172-25-001691.Report this figure | 8.9Current assets, Q1 FY2024, at 2024-03-31$8.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001493152-24-019225.Report this figure | 6.5Current assets, Q2 FY2024, at 2024-06-30$6.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001493152-24-030603.Report this figure | 8.2Current assets, Q3 FY2024, at 2024-09-30$8.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | 14.2Current assets, FY2024, at 2024-12-31$14.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-24, accession 0001193125-26-066965.Report this figure | 9.3Current assets, Q1 FY2025, at 2025-03-31$9.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | 10.2Current assets, Q2 FY2025, at 2025-06-30$10.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-31, accession 0000950170-25-100917.Report this figure | 5.2Current assets, Q3 FY2025, at 2025-09-30$5.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 6.3Current assets, FY2025, at 2025-12-31$6.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 2.9Current assets, Q1 FY2026, at 2026-03-31$2.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 5.9Current assets, Q2 FY2026, at 2026-06-30$5.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
| Total assets | $m | not reported | 11.8Total assets, FY2023, at 2023-12-31$11.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001641172-25-001691.Report this figure | 11.4Total assets, Q1 FY2024, at 2024-03-31$11.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001493152-24-019225.Report this figure | 8.9Total assets, Q2 FY2024, at 2024-06-30$8.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001493152-24-030603.Report this figure | 10.5Total assets, Q3 FY2024, at 2024-09-30$10.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | 16.4Total assets, FY2024, at 2024-12-31$16.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001193125-26-066965.Report this figure | 11.4Total assets, Q1 FY2025, at 2025-03-31$11.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | 13.9Total assets, Q2 FY2025, at 2025-06-30$13.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-31, accession 0000950170-25-100917.Report this figure | 8.7Total assets, Q3 FY2025, at 2025-09-30$8.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 9.6Total assets, FY2025, at 2025-12-31$9.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 5.9Total assets, Q1 FY2026, at 2026-03-31$5.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 7.9Total assets, Q2 FY2026, at 2026-06-30$7.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
| Current liabilities | $m | not reported | 9.2Current liabilities, FY2023, at 2023-12-31$9.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001641172-25-001691.Report this figure | 14.0Current liabilities, Q1 FY2024, at 2024-03-31$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001493152-24-019225.Report this figure | 10.1Current liabilities, Q2 FY2024, at 2024-06-30$10.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001493152-24-030603.Report this figure | 6.7Current liabilities, Q3 FY2024, at 2024-09-30$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | 12.7Current liabilities, FY2024, at 2024-12-31$12.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-24, accession 0001193125-26-066965.Report this figure | 8.2Current liabilities, Q1 FY2025, at 2025-03-31$8.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | 11.0Current liabilities, Q2 FY2025, at 2025-06-30$11.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-31, accession 0000950170-25-100917.Report this figure | 6.7Current liabilities, Q3 FY2025, at 2025-09-30$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 1.8Current liabilities, FY2025, at 2025-12-31$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 1.8Current liabilities, Q1 FY2026, at 2026-03-31$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 2.2Current liabilities, Q2 FY2026, at 2026-06-30$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
| Total liabilities | $m | not reported | 10.6Total liabilities, FY2023, at 2023-12-31$10.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001641172-25-001691.Report this figure | 15.3Total liabilities, Q1 FY2024, at 2024-03-31$15.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001493152-24-019225.Report this figure | 11.3Total liabilities, Q2 FY2024, at 2024-06-30$11.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001493152-24-030603.Report this figure | 7.7Total liabilities, Q3 FY2024, at 2024-09-30$7.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | 13.7Total liabilities, FY2024, at 2024-12-31$13.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-24, accession 0001193125-26-066965.Report this figure | 9.1Total liabilities, Q1 FY2025, at 2025-03-31$9.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | 13.0Total liabilities, Q2 FY2025, at 2025-06-30$13.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-31, accession 0000950170-25-100917.Report this figure | 8.6Total liabilities, Q3 FY2025, at 2025-09-30$8.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 3.5Total liabilities, FY2025, at 2025-12-31$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 3.3Total liabilities, Q1 FY2026, at 2026-03-31$3.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 3.3Total liabilities, Q2 FY2026, at 2026-06-30$3.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | 10.5Shareholders' equity, period not labelled, at 2023-09-30$10.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001493152-24-044736.Report this figure | 1.3Shareholders' equity, FY2023, at 2023-12-31$1.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-24, accession 0001193125-26-066965.Report this figure | (3.9)Shareholders' equity, Q1 FY2024, at 2024-03-31−$3.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | (2.4)Shareholders' equity, Q2 FY2024, at 2024-06-30−$2.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 2.7Shareholders' equity, Q3 FY2024, at 2024-09-30$2.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 2.7Shareholders' equity, FY2024, at 2024-12-31$2.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 2.4Shareholders' equity, Q1 FY2025, at 2025-03-31$2.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 0.9Shareholders' equity, Q2 FY2025, at 2025-06-30$860.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 0.1Shareholders' equity, Q3 FY2025, at 2025-09-30$125.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-31, accession 0001193125-25-260774.Report this figure | 6.2Shareholders' equity, FY2025, at 2025-12-31$6.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 2.6Shareholders' equity, Q1 FY2026, at 2026-03-31$2.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure | 4.6Shareholders' equity, Q2 FY2026, at 2026-06-30$4.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-328454.Report this figure |
Cash flow
| Line item | Unit | period not labelled2023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $k | (1,139)Operating cash flow, period not labelled, three months to 2023-09-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001493152-24-044736. Derived: 9-month figure less the 6-month figure.Report this figure | (1,601)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001641172-25-001691. Derived: 12-month figure less the 9-month figure.Report this figure | (4,275)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | (1,947)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0000950170-25-100917. Derived: 6-month figure less the 3-month figure.Report this figure | (2,606)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-31, accession 0001193125-25-260774. Derived: 9-month figure less the 6-month figure.Report this figure | (3,073)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | (5,275)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | (3,984)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001193125-26-328454. Derived: 6-month figure less the 3-month figure.Report this figure | (3,972)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-31, accession 0001193125-25-260774. Derived: 9-month figure less the 6-month figure.Report this figure | (3,163)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | (4,364)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | (3,291)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001193125-26-328454. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $k | 413Capital expenditure, period not labelled, three months to 2023-09-30$413.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001493152-24-044736. Derived: 9-month figure less the 6-month figure.Report this figure | 2.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001641172-25-001691. Derived: 12-month figure less the 9-month figure.Report this figure | 8.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001641172-25-010252.Report this figure | 66.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$66.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-31, accession 0000950170-25-100917. Derived: 6-month figure less the 3-month figure.Report this figure | 11.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-31, accession 0001193125-25-260774. Derived: 9-month figure less the 6-month figure.Report this figure | 99.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$99.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | 43.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$43.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 213Capital expenditure, Q2 FY2025, three months to 2025-06-30$213.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0001193125-26-328454. Derived: 6-month figure less the 3-month figure.Report this figure | 6.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-31, accession 0001193125-25-260774. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001193125-26-066965. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001193125-26-197858.Report this figure | 0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0001193125-26-328454. Derived: 6-month figure less the 3-month figure.Report this figure |
Shares
| Line item | Unit | period not labelled2023-03-31 | period not labelled2023-06-30 | period not labelled2023-09-30 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 28.2 | 28.2 | 28.2 | 31.1 | 32.7 | 33.5 | 1.8 | 1.9 | 43.1 | 3.8 | 6.3 |
Shares outstanding: 6.66m at Jul 31, 2026, from the cover of the 10-Q filed Jul 31, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.